Danish Covid-19 treatment approved for human trials

The goal of the new inhalation therapy is to also treat other infections such as influenza.

Photo: Marcus Emil Christensen

A new treatment for Covid-19, which is being developed by Danish scientists, has now been approved for its first clinical trial in humans, Danish hospital Rigshospitalet reports in a press release.

The treatment is an inhalation therapy where a patient is administered a mild acid solution to help the immune system fight infections in the airways.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs